Researchers at Genentech of South San Francisco and the Salk Institute of La Jolla have...
|
A new study published in the Proceedings of the National Academy of Sciences suggests that...
|
Any kind of severe brain injury increases the risk of
developing dementia later in life. Starting...
|
The positron
emission tomography (PET) scanning turned out to be a useful way of diagnosing
the...
|
Estrogen combined with standard antipsychotic drugs could
relieve symptoms of schizophrenia in...
|
Shares in the drug makers Wyeth and Elan
plunged on Wednesday after their experimental Alzheimer’s...
|
Two separate studies have linked schizophrenia to some
specific gene variations moving closer to...
|
The two companies that have discovered bapineuzumab, a drug that is supposed to slow down the...
|
The July 19 issue of The Lancet presents the findings of two Alzheimer related studies; while one...
|
Physical exercise appears to slow down the development of Alzheimer's disease. New research data,...
|
Scientists have
discovered a gene that almost doubles the risk of developing the most common
form...
|
Researchers are one step closer to understanding why Alzheimer's Disease develops. A team led by...
|
Myriad Genetics, Inc. has announced its upcoming Alzheimer drug Flurizan (tarenflurbil) which the...
|
Eli Lilly announced that it prepares a phase III trial for its experimental drug for Alzheimer's,...
|
A new drug that addresses schizophrenia symptoms has shown considerably less side effects than the...
|
A new study led by researchers at the Johns Hopkins
Bloomberg School of Public Health concluded...
|
